Towards improvements for penetrating the blood–brain barrier—recent progress from a material and pharmaceutical perspective

Q He, J Liu, J Liang, X Liu, W Li, Z Liu, Z Ding, D Tuo - Cells, 2018 - mdpi.com
The blood–brain barrier (BBB) is a critical biological structure that prevents damage to the
brain and maintains its bathing microenvironment. However, this barrier is also the obstacle …

Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders

E Gil-Martins, DJ Barbosa, V Silva, F Remião… - Pharmacology & …, 2020 - Elsevier
ABC (ATP-binding cassette) transporters represent one of the largest and most diverse
superfamily of proteins in living species, playing an important role in many biological …

Blood–brain barrier endothelial cells in neurodegenerative diseases: signals from the “barrier”

Y Yuan, J Sun, Q Dong, M Cui - Frontiers in Neuroscience, 2023 - frontiersin.org
As blood–brain barrier (BBB) disruption emerges as a common problem in the early stages
of neurodegenerative diseases, the crucial roles of barrier-type brain endothelial cells …

Astrocyte-derived paracrine signals: relevance for neurogenic niche regulation and blood–brain barrier integrity

SF Spampinato, V Bortolotto, PL Canonico… - Frontiers in …, 2019 - frontiersin.org
Astrocytes are essential for proper regulation of the central nervous system (CNS).
Importantly, these cells are highly secretory in nature. Indeed they can release hundreds of …

Disease-induced modulation of drug transporters at the blood–brain barrier level

SB Al Rihani, LI Darakjian, M Deodhar, P Dow… - International Journal of …, 2021 - mdpi.com
The blood–brain barrier (BBB) is a highly selective and restrictive semipermeable network of
cells and blood vessel constituents. All components of the neurovascular unit give to the …

Two decades-long journey from riluzole to edaravone: revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics

RP Dash, RJ Babu, NR Srinivas - Clinical pharmacokinetics, 2018 - Springer
The recent approval of edaravone has provided an intravenous option to treat amyotrophic
lateral sclerosis (ALS) in addition to the existing oral agent, riluzole. The present work was …

Excess glutamate secreted from astrocytes drives upregulation of P-glycoprotein in endothelial cells in amyotrophic lateral sclerosis

LA Mohamed, SS Markandaiah, S Bonanno… - Experimental …, 2019 - Elsevier
In amyotrophic lateral sclerosis (ALS), upregulation in expression and activity of the ABC
transporter P-glycoprotein (P-gp) driven by disease advancement progressively reduces …

Role of interleukin-6 and interleukin-10 in morphological and functional changes of the blood–brain barrier in hypertriglyceridemia

B Barabási, L Barna, AR Santa-Maria… - Fluids and Barriers of …, 2023 - Springer
Background Hypertriglyceridemia is closely linked to atherosclerosis related inflammatory
processes and blood–brain barrier (BBB) dysfunction. Using apolipoprotein B-100 (APOB …

Breached barriers: a scoping review of blood-central nervous system barrier pathology in amyotrophic lateral sclerosis

A Mirian, A Moszczynski, S Soleimani… - Frontiers in Cellular …, 2022 - frontiersin.org
Introduction Recent studies have implicated changes in the blood-central nervous system
barriers (BCNSB) in amyotrophic lateral sclerosis (ALS). The objective of this scoping review …

Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment

JCS Chaves, SJ Dando, AR White, LE Oikari - Biochimica et Biophysica …, 2023 - Elsevier
The blood-brain-barrier (BBB) has a major function in maintaining brain homeostasis by
regulating the entry of molecules from the blood to the brain. Key players in BBB function are …